Pediatrics

Organic vs Non-Organic Causes

Organic FTT reflects an identifiable underlying medical condition impairing growth: inadequate intake (organic cause, e.g., significant oromotor dysfunction/dysphagia), inadequate absorption (celiac disease, cystic fibrosis, significant chronic diarrheal illness), increased metabolic demand/loss (chronic infection, congenital heart disease, chronic renal disease, other significant chronic systemic illness), and impaired utilization (certain inborn errors of metabolism).

Non-Organic FTT (historically the more commonly identified category, though the dichotomy is increasingly recognized as often overlapping) reflects inadequate growth without an identifiable organic cause, typically related to psychosocial factors — inadequate caloric provision (feeding knowledge/technique difficulties, poverty/food insecurity, or neglect in more concerning cases), disrupted parent-child feeding interaction/attachment difficulties, or significant maternal mental health issues (postpartum depression impairing consistent, attentive feeding/care). Even predominantly “non-organic” cases still require careful exclusion of a contributing organic component.

Anthropometric Criteria

Generally defined using: weight-for-age below the 3rd–5th percentile on more than one occasion, weight crossing down through 2 or more major percentile lines over time (often more sensitive than a single low percentile value, since a child consistently tracking at a low percentile may simply reflect their own normal, stable pattern), or weight-for-height below the 5th percentile — with weight typically affected before height, and height before head circumference, in the natural progression of an ongoing deficit (analogous to the acute-vs-chronic malnutrition distinction — wasting vs stunting).

Clinical Evaluation and Caloric Requirements

Comprehensive evaluation: detailed feeding history, growth trajectory review, thorough general examination screening for underlying organic causes, and careful psychosocial assessment (family circumstances, feeding environment, caregiver mental health/support). Caloric requirements for catch-up growth typically exceed standard age-appropriate maintenance requirements, since additional calories beyond maintenance support the accelerated “catch-up” growth needed — with careful monitoring of growth response serving both a therapeutic and diagnostic role (robust growth response with adequate, reliably provided intake supports non-organic classification; continued poor growth despite confirmed adequate intake should prompt renewed evaluation for a missed organic cause).

Psychosocial Intervention

For cases with an identified/suspected significant psychosocial component: parental feeding education/support, structured feeding intervention programs (sometimes involving direct observation of feeding interactions), maternal mental health screening/support/referral, broader family/social support service engagement where significant psychosocial stressors are identified, and, in cases raising specific neglect concern, appropriate engagement with child protection services following relevant safeguarding protocols.

Specific Learning Disorders (SLD)

DSM-5 defines Specific Learning Disorder as persistent difficulty learning and using specific academic skills (reading, written expression, and/or mathematics), with performance substantially and quantifiably below expected for chronological age despite provision of targeted interventions, and — critically, a central distinguishing feature — occurring in a child with otherwise average or above-average general intellectual ability (distinguishing SLD from intellectual disability/GDD, where academic difficulty reflects generalized cognitive limitation rather than a specific, circumscribed impairment despite otherwise intact general cognition). SLD is further specified by domain: reading (dyslexia — the most common and extensively studied subtype), written expression (dysgraphia), and mathematics (dyscalculia).

Recognition

Clinical suspicion typically arises from unexpected academic underachievement in a specific domain, disproportionate to demonstrated general cognitive ability and effort, and not adequately explained by other factors (inadequate instruction/opportunity, uncorrected sensory impairment, or a primary intellectual/developmental disability). Dyslexia specifically presents with characteristic phonological processing/awareness difficulties (relating written letters to their sounds), slow, effortful, inaccurate reading, and spelling difficulty, often first apparent as formalized reading instruction begins in early school years.

Diagnostic Assessment Tools

Formal diagnosis requires a comprehensive psychoeducational assessment: standardized cognitive/IQ testing (confirming average/above-average general intellectual ability, excluding global intellectual disability) alongside standardized academic achievement testing in the specific suspected domain — formally demonstrating and quantifying the significant discrepancy between general cognitive ability and achievement in the affected domain. This assessment is typically conducted by an appropriately trained specialist (educational psychologist or similarly qualified professional), with pediatric clinical recognition and timely referral representing an essential first step.

Educational Accommodations and Remedial Teaching

Management centers on structured educational intervention rather than medical/pharmacological treatment (no pharmacological therapy exists for SLD itself, distinguishing management from the pharmacological component relevant to frequently co-occurring conditions like ADHD, Q69): specific, evidence-based remedial teaching (e.g., structured, systematic phonics-based instruction for dyslexia), and educational accommodations (extended examination time, alternative assessment formats, assistive technology such as text-to-speech, preferential seating/instructional modifications) implemented through a formalized, individualized educational plan developed collaboratively between educational specialists, the school, and the family — with the pediatrician's role centering on early recognition, appropriate referral for formal assessment, ongoing developmental/psychosocial support, and coordination of care for co-occurring conditions.

Depression in Adolescents

Can present with the classically-described adult symptom pattern (persistent low mood, anhedonia, sleep/appetite disturbance, fatigue, difficulty concentrating), but frequently shows notable age-specific variation: irritability may predominate over, or substitute for, overtly sad/depressed mood (an important distinguishing point from typical adult presentation); somatic complaints (headache, abdominal pain, fatigue without a clear organic cause) are common, sometimes prompting extensive medical evaluation before the underlying mood disorder is recognized; and declining academic performance, social withdrawal, and behavioral changes (increased conflict, risk-taking) may be the most clinically apparent presenting features rather than an explicit report of low mood.

Anxiety Disorders

Encompass generalized anxiety disorder, social anxiety disorder (of particular developmental salience given heightened importance of peer relationships/social standing during adolescence), panic disorder, and specific phobias — presenting with both psychological symptoms (excessive, difficult-to-control worry, specific fears) and frequently prominent somatic/physical manifestations (palpitations, GI symptoms, headache), which, as with depression, can lead to initial medical rather than mental health-focused evaluation.

Risk of Suicide

A major, leading cause of adolescent mortality globally — screening for suicide risk (embedded in the HEADSSS “Suicide/Depression” domain, Q73) is essential, standard practice. Recognized risk factors: pre-existing mood or other psychiatric disorder, prior suicide attempt (a particularly strong risk factor), substance use, significant psychosocial stressors (bullying, family conflict, relationship loss, academic pressure — of particular relevance in some educational/cultural contexts including India), access to lethal means, and family history of suicide. Clinical assessment requires direct, explicit, non-judgmental inquiry regarding suicidal ideation, specific plans, and access to means — directly asking about suicidal thoughts does not increase risk and is an essential, necessary component of appropriate risk assessment.

Screening Tools

Validated instruments (PHQ-9 modified for adolescents, GAD-7 for anxiety) provide structured, standardized tools for systematic mental health screening, facilitating more reliable identification than spontaneous disclosure or informal clinical impression alone, particularly given the somatic/behavioral rather than explicitly mood-focused presentation pattern common in this age group.

Principles of Cognitive Behavioral Therapy

CBT is the first-line, most extensively evidence-supported psychotherapeutic approach for both adolescent depression and anxiety, working on the principle that thoughts, feelings, and behaviors are interconnected — systematically identifying and restructuring maladaptive, distorted thought patterns (cognitive restructuring) combined with structured behavioral intervention (graduated exposure-based techniques for anxiety; structured behavioral activation for depression, countering withdrawal/avoidance) produces meaningful symptom improvement. CBT is typically a structured, time-limited course, and for moderate-severe presentations is frequently combined with pharmacological treatment (SSRIs, with fluoxetine carrying the most robust pediatric/adolescent-specific evidence and regulatory approval among the SSRI class) as part of a comprehensive, combined treatment approach.

Concept

Primitive reflexes are stereotyped, involuntary motor responses to specific sensory stimuli, mediated at the brainstem/spinal cord level, present in the normal newborn/young infant, and expected to progressively disappear (“integrate”) as higher cortical centers mature and develop increasing inhibitory control over these more primitive circuits — the expected pattern of appearance and disappearance provides a valuable window into nervous system maturation, making primitive reflex assessment a core component of the pediatric neurological/developmental examination, particularly in infancy.

Key Primitive Reflexes — Timing and Significance

Overall Clinical Significance

Primitive reflex assessment provides diagnostically valuable information in two directions: persistence beyond the expected disappearance age suggests delayed CNS maturation or an underlying static/progressive neurological abnormality (most classically cerebral palsy, Q72), while absence of an expected reflex at the appropriate age, or asymmetry, can indicate significant CNS depression/dysfunction or, particularly with asymmetry, a focal peripheral or central lesion — making primitive reflex assessment a genuinely bidirectionally-informative, low-cost, readily-performed component of standard pediatric neurological/developmental examination, particularly valuable in infants at risk for or with suspected developmental delay/cerebral palsy.

Principle of Bone Age Assessment

Bone age assessment is based on the well-characterized, predictable, sequential pattern of ossification center appearance and, subsequently, epiphyseal fusion at growth plates of specific bones (most commonly a standardized radiograph of the left hand and wrist, given numerous sequentially-maturing growth centers within this single, readily and safely imaged region). Comparing a child's actual radiographic bone maturation pattern against age- and sex-specific reference standards determines “bone age” — a measure of skeletal maturity, which may be concordant with, advanced relative to, or delayed relative to chronological age.

Greulich-Pyle Atlas Method

The traditional, most widely used method — visual comparison of the hand/wrist radiograph against a published reference atlas of standardized representative reference radiographs for each age/sex, with the assessor selecting the closest matching reference image. Relatively rapid and extensively validated, but subjective, holistic pattern-matching with resulting inter-observer variability, and originally developed/validated using a specific reference population (a particular ethnic/geographic background), raising some question of precise applicability across diverse global populations — though remains very widely used given its established track record and practical convenience.

Tanner-Whitehouse (TW) Method

An alternative, more detailed, systematic scoring methodology — individual assessment/scoring of the maturational stage of a defined series of specific individual bones (rather than a single holistic whole-radiograph comparison), with individual bone scores combined via a standardized formula to derive an overall bone age. Offers greater objectivity/reproducibility (more granular, itemized, quantitative scoring, reducing reliance on subjective holistic pattern-matching), at the cost of being more time-consuming to perform in routine practice — a recognized trade-off between assessment precision/reproducibility and practical clinical efficiency.

Clinical Utility in Pediatric Endocrinology

• Distinguishing familial short stature from CDGP (concordant versus delayed bone age respectively, Q68)
• Supporting or refuting a diagnosis of precocious puberty (characteristically advanced bone age, reflecting premature sex steroid exposure, Q71)
• Predicting adult height potential (standardized prediction formulas incorporating current height and bone age) — valuable for counseling and monitoring response to growth-promoting therapies
• Monitoring therapeutic response to hormone replacement/suppression therapies (GnRH agonist therapy for central precocious puberty, or growth hormone therapy) — serial bone age assessment helps confirm appropriate treatment effect and guide ongoing management
• Providing general supportive diagnostic evidence within the broader evaluation of suspected endocrine or chronic systemic disorders affecting growth, many of which characteristically produce a delayed bone age pattern

Q84. Discuss the management of Severe Acute Malnutrition (SAM), including the WHO 10-step protocol, the composition of F-75 and F-100 feeds, and the pathophysiological basis for cautious feeding.

Definition and Classification

SAM is defined by weight-for-height/length z-score <-3 SD, mid-upper arm circumference (MUAC) <11.5 cm (in children 6–59 months), or the presence of bilateral pitting edema (defining kwashiorkor-type/edematous SAM, regardless of the weight-for-height measurement). The three criteria are used somewhat interchangeably/complementarily for case identification, with MUAC particularly valued for its simplicity and applicability in community-based screening, since it requires no weighing scale/height board, and has independently been shown to correlate strongly with mortality risk.

Pathophysiological Basis for Cautious Management

Severely malnourished children undergo profound metabolic adaptation to chronic starvation — reduced basal metabolic rate, altered electrolyte handling (with intracellular potassium and phosphate depletion despite sometimes normal-appearing serum levels), impaired cardiac function (reduced cardiac reserve), and compromised hepatic/renal/immune function. This adapted, fragile physiological state means that standard, "generous" feeding and fluid approaches used in well-nourished children are actively dangerous in SAM — rapid reintroduction of carbohydrate-rich feeding triggers a sudden insulin surge, driving potassium, phosphate, and magnesium sharply into cells (refeeding syndrome), which can precipitate fatal cardiac arrhythmias, and standard fluid volumes can precipitate heart failure given the compromised cardiac reserve.

WHO 10-Step Management Protocol

1. Treat/prevent hypoglycemia: blood glucose <54 mg/dL is treated immediately with oral/NG glucose or sugar water if conscious, or IV glucose if unconscious; frequent feeding (every 2–3 hours, including through the night) is instituted to prevent recurrence, given markedly reduced glycogen reserves and impaired gluconeogenic capacity.
2. Treat/prevent hypothermia: impaired thermoregulation (reduced subcutaneous fat, impaired metabolic heat generation) — warming measures (skin-to-skin/kangaroo-style warming, warm room, covering the head), and frequent temperature monitoring.
3. Treat/prevent dehydration: clinical assessment of dehydration is notoriously unreliable in SAM (edema can mask true dehydration; loss of subcutaneous fat alters skin turgor assessment). Standard WHO/IMNCI ORS is NOT used, given its sodium content is excessive for the SAM child's altered physiology (total body sodium is often already elevated despite low serum levels) — instead, a specific lower-sodium, higher-potassium oral rehydration solution (ReSoMal) is used, given slowly and in smaller volumes than standard rehydration protocols, with frequent reassessment.
4. Correct electrolyte imbalance: proactive potassium and magnesium supplementation is given to all SAM children (rather than only those with a documented low serum level), and sodium intake is restricted even in the presence of apparent dehydration, reflecting total-body sodium excess.
5. Treat/prevent infection: given blunted/atypical immune responses in SAM (fever may be absent even with significant infection), broad-spectrum antibiotics are given empirically to all SAM children with complications, rather than withheld pending confirmed clinical signs of infection.
6. Correct micronutrient deficiencies: multivitamins, folic acid, and other micronutrients are given, but iron is deliberately WITHHELD during the initial stabilization phase — iron administered during active infection/inflammation and before metabolic stabilization can promote bacterial growth and generate free-radical-mediated tissue injury; iron is introduced only once the child enters the rehabilitation phase and is gaining weight.
7. Start cautious feeding (stabilization phase): initiated with F-75 therapeutic milk, formulated to provide just enough energy to meet basal metabolic needs without overwhelming the fragile, adapted metabolic/cardiac system — given in small, frequent volumes (every 2–3 hours).
8. Achieve catch-up growth (rehabilitation phase): once stabilized (edema reducing, appetite returning, no significant medical complications), a gradual transition to F-100 (higher energy/protein density) is made over several days, allowing time to adapt without precipitating refeeding syndrome.
9. Provide sensory stimulation and emotional support: structured play therapy and emotional stimulation, given SAM's well-documented adverse impact on neurodevelopment.
10. Prepare for follow-up after discharge/recovery: a structured plan for continued nutritional support, growth monitoring, and identification/management of underlying contributing factors (food insecurity, feeding practices, underlying illness), to reduce relapse risk.

F-75 and F-100 Composition

Refeeding Syndrome — Pathophysiology

Occurs when carbohydrate reintroduction after a period of starvation triggers insulin release, driving phosphate, potassium, and magnesium into cells, causing severe extracellular depletion of these ions. Hypophosphatemia is the most clinically dangerous consequence, given phosphate's essential role in ATP synthesis; severe hypophosphatemia can cause cardiac dysfunction/failure, respiratory muscle weakness (precipitating respiratory failure), rhabdomyolysis, and hemolysis. This is the precise physiological threat that Steps 3, 4, and 7 of the WHO protocol are specifically designed to prevent.

Criteria for Discharge

• Weight-for-height/length z-score consistently ≥-2 SD (or MUAC ≥12.5 cm)
• Resolution of edema for at least 2 weeks (edematous SAM requires a defined edema-free period, since edema resolution alone does not guarantee full metabolic recovery)
• Good appetite with tolerance of an adequate, age-appropriate diet
• Resolution of any medical complications
• Confirmation of appropriate follow-up/community-based nutritional support arrangements

Many children, particularly those without significant medical complications, transition to community-based management with Ready-to-Use Therapeutic Food (RUTF) once the acute stabilization phase is complete, rather than requiring prolonged inpatient rehabilitation-phase management — reflecting the broader global shift toward community-based therapeutic care (CMAM) models for uncomplicated SAM.

Q85. Differentiate between Nutritional (Vitamin D deficiency) Rickets and Hypophosphatemic (Vitamin D-refractory) Rickets, including pathophysiology, biochemical/radiological findings, and treatment.

Pathophysiology of Nutritional (Vitamin D Deficiency) Rickets

Vitamin D, obtained through cutaneous synthesis (UVB-mediated conversion of 7-dehydrocholesterol) and dietary intake, undergoes sequential hepatic 25-hydroxylation (producing 25-OH-Vitamin D, the primary circulating storage form) and renal 1α-hydroxylation (producing the biologically active 1,25-dihydroxyvitamin D). Active vitamin D promotes intestinal calcium and phosphate absorption; its deficiency causes reduced intestinal calcium absorption, triggering secondary hyperparathyroidism (PTH mobilizes calcium from bone and promotes renal phosphate wasting) — this combined calcium-phosphate deficit at the growth plate impairs normal endochondral ossification, producing the characteristic rachitic changes.

Biochemical Findings – Comparison Table

Radiological Features (Nutritional Rickets)

• Cupping and fraying of the metaphyses (distal radius/ulna, costochondral junctions — "rachitic rosary")
• Widening of the growth plate
• Bowing of weight-bearing long bones (once ambulatory)
• Generalized osteopenia

Therapeutic Regimens for Nutritional Rickets

Stoss therapy — a single, large "mega-dose" of Vitamin D (commonly 300,000–600,000 IU, given as a single oral or intramuscular dose), particularly practical where adherence to prolonged daily dosing may be unreliable — widely used in the Indian context. Alternative daily dosing: typically 2,000–4,000 IU/day for 6–12 weeks, an accepted alternative where reliable adherence can be assured.

Hypophosphatemic Rickets (Vitamin D-Refractory Rickets)

In sharp contrast to nutritional rickets, this results from a primary defect in renal phosphate handling, causing excessive renal phosphate wasting independent of vitamin D status. The most common form, X-linked hypophosphatemic rickets, results from mutations in the PHEX gene, causing excess circulating FGF-23 (fibroblast growth factor 23), which drives renal phosphate wasting and also suppresses renal 1α-hydroxylase activity — meaning active vitamin D levels are inappropriately low-normal relative to the degree of hypophosphatemia, rather than showing the expected compensatory rise.

Treatment of Hypophosphatemic Rickets

Requires oral phosphate supplementation combined with active vitamin D (calcitriol) rather than standard vitamin D, since the kidneys cannot adequately activate standard (25-OH) vitamin D. Burosumab, a monoclonal antibody targeting FGF-23 directly, represents an important, emerging targeted therapy specifically for X-linked hypophosphatemic rickets, addressing the root molecular cause rather than simply replacing the downstream deficient substrate.

Q86. Discuss Total Parenteral Nutrition (TPN) in pediatrics: indications, calculation principles, and major complications.

Indications

TPN is indicated when the gastrointestinal tract cannot be used safely or adequately to meet a child's nutritional requirements, including:

• Significant intestinal failure (short bowel syndrome following extensive surgical resection, e.g., post-NEC)
• Severe malabsorption
• Prolonged ileus/bowel obstruction
• Severe necrotizing enterocolitis requiring bowel rest
• Certain severe inflammatory bowel disease exacerbations
• A bridging nutritional support measure in extremely preterm infants before full enteral feeding can be established

Calculation of Fluid and Macronutrient Requirements

Fluid: follows standard pediatric maintenance principles (e.g., Holliday–Segar method), adjusted for context (increased in preterm infants given higher insensible losses; restricted in fluid-overload states).

Amino acids (protein): introduced early (even from day 1 in critically ill/preterm infants, favoring early protein provision to minimize catabolism) and advanced incrementally toward age-appropriate targets (higher g/kg/day in preterm/younger infants).

Lipid emulsions: provide concentrated calories and essential fatty acids, introduced and advanced gradually with monitoring for hypertriglyceridemia. Modern mixed/multi-oil emulsions (incorporating fish oil, providing omega-3 fatty acids) are increasingly preferred over pure soybean-oil-based emulsions, given a more favorable inflammatory profile and reduced TPN-associated cholestasis risk.

Dextrose (carbohydrate): provides the majority of total caloric intake, with infusion rate carefully titrated to avoid both hypoglycemia and hyperglycemia, advanced gradually to avoid overwhelming glucose tolerance.

Electrolyte Additives

Sodium, potassium, calcium, phosphate, and magnesium are added based on individualized requirements and ongoing monitoring — with particular attention to calcium-phosphate solubility/precipitation risk within the TPN solution (a catastrophic embolic risk if precipitate forms), and to refeeding-type electrolyte derangements in malnourished children requiring TPN initiation.

Complications

TPN Cholestasis

A particularly important, frequently-tested complication, especially in prolonged neonatal/young infant TPN use, presenting with progressive direct hyperbilirubinemia and other cholestatic biochemical changes. Multifactorial pathogenesis:

• Absence of enteral feeding itself (enteral nutrition stimulates bile flow and gut hormone release; prolonged bowel rest disrupts this)
• Potential hepatotoxic effects of specific TPN components (historically implicated with traditional soybean-oil-predominant lipid emulsions)
• The underlying intestinal failure/disease process itself

Management emphasizes: initiating and advancing enteral feeding as early/as much as tolerated (even trophic minimal-volume feeds help), cyclic (rather than continuous 24-hour) TPN infusion where feasible, and use of mixed-oil lipid emulsion formulations.

Line Sepsis (CLABSI)

TPN requires central venous access, carrying inherent infection risk, managed through standardized central line insertion and maintenance care bundles.

Metabolic Derangements

Hyperglycemia/hypoglycemia, electrolyte disturbances, hypertriglyceridemia (from lipid infusion, particularly with rapid advancement or impaired lipid clearance), and, with long-term use, essential fatty acid deficiency (if lipid provision is inadequate) and metabolic bone disease.

Q87. Discuss the approach to Inborn Errors of Metabolism (IEM) presenting in neonates, including the intoxication vs energy-failure classification and the emergency diagnostic algorithm.

Why Neonatal IEM Presentation Requires a Structured Approach

Neonatal-onset IEM presentations are notoriously clinically non-specific — poor feeding, vomiting, lethargy, altered tone, seizures, and respiratory distress overlap substantially with sepsis (which must always be considered and empirically covered in parallel, since IEM and sepsis can be difficult to distinguish clinically and occasionally co-exist or precipitate one another). A structured, biochemistry-driven diagnostic algorithm is essential for timely diagnosis in this time-critical population.

The Two Fundamental Pathophysiological Categories

"Intoxication Type" Disorders

Accumulation of a toxic metabolite proximal to a specific enzymatic block. The infant typically appears entirely well at birth (protected in utero by maternal/placental clearance), followed by a symptom-free interval (hours to a few days) before progressive deterioration begins postnatally. Includes: urea cycle disorders, organic acidemias, classic galactosemia, and maple syrup urine disease.

"Energy Failure/Deficiency Type" Disorders

Impaired capacity to generate or utilize cellular energy, including fatty acid oxidation defects, mitochondrial disorders, and glycogen storage diseases. Often precipitated/unmasked by a specific metabolic stressor (fasting, intercurrent illness) rather than a fixed postnatal symptom-free interval, and often present with prominent hypoglycemia.

Emergency Diagnostic Algorithm

Step 1 – Initial Rapid Screening

Blood glucose, blood gas (attention to anion gap), serum ammonia, and serum lactate:

Step 2 – Second-Tier, Specific Testing

• Plasma amino acid profile — urea cycle disorders and aminoacidopathies (e.g., MSUD, PKU)
• Urine organic acids — key test for organic acidemias
• Acylcarnitine profile (tandem mass spectrometry) — key test for fatty acid oxidation defects and many organic acidemias

Step 3 – Tandem Mass Spectrometry (MS/MS)

Has revolutionized IEM diagnosis by allowing simultaneous, rapid screening of numerous amino acid and acylcarnitine species from a single small blood sample — the technological backbone of expanded newborn screening programs, and also useful for rapid diagnostic support in the acute symptomatic neonate.

General Emergency Management Principles

• Stop protein intake immediately
• Provide high-calorie, protein-free glucose infusion to suppress catabolism (actively preventing catabolism, not just withholding nutrition)
• Correct any hypoglycemia and significant acidosis
• Consider specific interventions for confirmed/strongly suspected conditions (e.g., nitrogen scavenger therapy for hyperammonemia; cofactor trials such as biotin, thiamine, or carnitine)
• Hemodialysis/hemofiltration for severe, rapidly rising hyperammonemia not responding to medical therapy alone

Q88. Discuss Pediatric Obesity and Metabolic Syndrome: diagnostic criteria, complications, and management.

IDF/AAP Criteria for Metabolic Syndrome in Children

Generally requires central/abdominal obesity (waist circumference above an age/sex-specific percentile threshold) as an essential prerequisite criterion, plus at least two of the following:

• Elevated triglycerides
• Reduced HDL cholesterol
• Elevated blood pressure (per pediatric hypertension percentile-based definitions)
• Elevated fasting glucose or established impaired glucose tolerance/type 2 diabetes

Complications

• Non-Alcoholic Fatty Liver Disease (NAFLD) — now the most common chronic liver disease in children in many populations, ranging from simple steatosis to NASH with fibrosis risk
• Dyslipidemia — elevated triglycerides, reduced HDL, small dense LDL particles (atherogenic profile)
• Insulin resistance progressing in a subset to overt type 2 diabetes mellitus — a significant shift from historical patterns of near-exclusively type 1 pediatric diabetes
• Obstructive Sleep Apnea Syndrome (OSAS) — independent cardiometabolic and neurocognitive consequences
• Orthopedic complications (slipped capital femoral epiphysis, Blount disease)
• Polycystic ovary syndrome in adolescent girls
• Significant psychosocial/mental health impact (depression, anxiety, low self-esteem, stigmatization)

Management

Lifestyle Intervention (First-Line, Foundational)

• Structured dietary modification (reduced sugar-sweetened beverages/processed foods, increased fruit/vegetable intake, portion control)
• Increased physical activity with evidence-based screen time reduction targets
• Family-based behavioral intervention — engaging the whole household, since this produces superior outcomes over child-isolated intervention

Pharmacological Intervention

Considered for more severe obesity with significant comorbidity and inadequate response to intensive lifestyle intervention. GLP-1 receptor agonists represent an important, evolving, and increasingly available option in adolescents with obesity, reflecting a significant recent expansion of the pediatric pharmacological treatment landscape.

Bariatric Surgery

Reserved for carefully selected adolescents with severe obesity and significant comorbidity who have not achieved adequate benefit from comprehensive lifestyle and pharmacological intervention, following rigorous multidisciplinary evaluation and readiness assessment.